GR71886B - - Google Patents

Info

Publication number
GR71886B
GR71886B GR56036A GR780156036A GR71886B GR 71886 B GR71886 B GR 71886B GR 56036 A GR56036 A GR 56036A GR 780156036 A GR780156036 A GR 780156036A GR 71886 B GR71886 B GR 71886B
Authority
GR
Greece
Application number
GR56036A
Other languages
Greek (el)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/871,563 external-priority patent/US4116951A/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of GR71886B publication Critical patent/GR71886B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57581—Thymosin; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
GR56036A 1977-04-22 1978-04-20 GR71886B (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78989877A 1977-04-22 1977-04-22
US05/871,563 US4116951A (en) 1977-04-22 1978-01-23 [Asn2 ]-thymosin α1 and analogs thereof

Publications (1)

Publication Number Publication Date
GR71886B true GR71886B (en:Method) 1983-08-04

Family

ID=27120967

Family Applications (1)

Application Number Title Priority Date Filing Date
GR56036A GR71886B (en:Method) 1977-04-22 1978-04-20

Country Status (18)

Country Link
JP (1) JPS53137914A (en:Method)
AT (1) AT364470B (en:Method)
CA (1) CA1113088A (en:Method)
CH (3) CH641152A5 (en:Method)
DE (1) DE2817082A1 (en:Method)
DK (1) DK147918C (en:Method)
ES (1) ES469016A1 (en:Method)
FI (1) FI781241A7 (en:Method)
FR (2) FR2401134A1 (en:Method)
GB (1) GB1590668A (en:Method)
GR (1) GR71886B (en:Method)
HU (1) HU180783B (en:Method)
IT (1) IT1113134B (en:Method)
LU (1) LU79488A1 (en:Method)
NL (1) NL7804364A (en:Method)
NO (2) NO781404L (en:Method)
PT (1) PT67937B (en:Method)
SE (1) SE447262B (en:Method)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4116951A (en) * 1977-04-22 1978-09-26 Hoffmann-La Roche Inc. [Asn2 ]-thymosin α1 and analogs thereof
DE2919592A1 (de) * 1979-05-15 1981-01-15 Max Planck Gesellschaft Verfahren zur herstellung von thymosin- alpha 1 und derivaten davon
EP0033384B1 (de) * 1980-01-18 1984-02-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Thymosin-alpha-1-Fragmente enthaltende Arzneimittel mit immunstimulierender Wirkung, und Thymosin-alpha-1-Fragmente
US4339427A (en) * 1980-04-14 1982-07-13 Hoffmann-La Roche Inc. Radioimmunoassay of thymosinα
EP0056594B1 (de) * 1981-01-14 1984-09-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Thymosin-alpha-1-Fragmente enthaltende Arzneimittel mit immunregulierender Wirkung und Thymosin-alpha-1-Fragmente
CN1058500C (zh) * 1993-02-03 2000-11-15 施塞克龙药品公司 胸腺素α-1衍生物
US6262230B1 (en) * 1994-01-28 2001-07-17 Sciclone Pharmaceuticals Inc. Analogs of thymosin α1

Also Published As

Publication number Publication date
DK147918C (da) 1985-08-19
DK147918B (da) 1985-01-07
JPS53137914A (en) 1978-12-01
SE447262B (sv) 1986-11-03
NO781404L (no) 1978-10-24
PT67937B (en) 1980-04-07
NO821608L (no) 1978-10-24
CH640218A5 (en) 1983-12-30
FR2405926B1 (en:Method) 1983-09-09
DE2817082A1 (de) 1978-11-02
NO148924B (no) 1983-10-03
IT1113134B (it) 1986-01-20
ATA286178A (de) 1981-03-15
HU180783B (en) 1983-04-29
NL7804364A (nl) 1978-10-24
CH641153A5 (en) 1984-02-15
PT67937A (en) 1978-05-01
DK169478A (da) 1978-10-23
FR2405926A1 (fr) 1979-05-11
NO148924C (no) 1984-01-11
FR2401134A1 (fr) 1979-03-23
ES469016A1 (es) 1980-01-01
AT364470B (de) 1981-10-27
GB1590668A (en) 1981-06-03
CA1113088A (en) 1981-11-24
IT7822629A0 (it) 1978-04-21
LU79488A1 (de) 1979-05-25
CH641152A5 (en) 1984-02-15
FR2401134B1 (en:Method) 1983-09-30
SE7804612L (sv) 1978-12-20
FI781241A7 (fi) 1978-10-23

Similar Documents

Publication Publication Date Title
FR2378276B1 (en:Method)
FR2377640B1 (en:Method)
FR2376690B3 (en:Method)
FI782264A7 (en:Method)
FR2405926B1 (en:Method)
FR2377226B1 (en:Method)
FR2378870B2 (en:Method)
CH631858GA3 (en:Method)
AR210643A1 (en:Method)
AU71461S (en:Method)
DK9777A (en:Method)
BG25822A1 (en:Method)
BE851449A (en:Method)
BG25810A1 (en:Method)
BG25850A1 (en:Method)
BG25839A1 (en:Method)
BG24713A1 (en:Method)
BG25860A1 (en:Method)
BG25809A1 (en:Method)
BG25827A2 (en:Method)
BG25826A1 (en:Method)
BG25844A1 (en:Method)
CH610704GA3 (en:Method)
BE866391A (en:Method)
BG24331A1 (en:Method)